LeállítvaFázis nélkül
Timing of Revascularization in Patients With Diabetic Foot Ulcer and Non-critical Peripheral Artery Disease
A legfontosabb adatok
- Ki végzi
- Insel Gruppe AG, University Hospital Bern
- Hol
- Svájc4 helyszín, 1 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Leállítva
- Résztvevők
- 10 fő vett részt
- Kezdés
- 2022. jan. 25.
- Befejezés
- 2024. szept. 18.
- A vizsgálat típusa
- Beavatkozással járó, 2 csoportAz egyik csoport egy már használt kezelést kap, összehasonlításként.
- A vizsgált kezelések
- Revascularization
- Standard wound care
- A regiszteradat frissítve
- 2024. december 19.
- Miért állt le
- High pre-screening failure and insufficient recruited patients
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 17 feltétel megnézéseKevesebb
Ki vehet részt
- Informed consent as documented by signature
- Patients that are at least 18 years old
- Patients that have at least one DFU(s) of ≥ 0.2 cm2 and ≤ 10 cm2 as assessed by the ruler method multiplying the greatest length and width of the ulcer after debridement to determine the surface area. The largest eligible ulcer (≤ 10 cm2) will be defined as index ulcer and the corresponding extremity as index limb (in case of multiple equally sized ulcers the following rules will apply: If on different feet, the dominant side and if on the same foot, the more peripheral one will be the index ulcer)
- Patients that have non-critical LEAD of the index leg, defined by a single non-invasive examination at screening:; Ankle brachial index (ABI) ≥ 0.5 and ≤ 0.9 AND absolute ankle pressure ≥ 50 mmHg OR; ABI > 0.9 OR incompressible ankle pressures AND toe brachial index (TBI) ≤ 0.7 AND absolute toe pressure ≥ 30 mmHg
- Patients on medical treatment for glycemic control with diagnosis of diabetes mellitus that was assessed by criteria as recommended by the guideline 2019 "ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD". Or patient without medical treatment but diagnosed with diabetes mellitus via HbA1c
- Patients with life expectancy > 12 months and without any disabilities due to end-stage cancer, heart failure, severe chronic obstructive pulmonary disease (COPD), or dementia
Ki nem vehet részt
- Any revascularization procedure at the index leg within 3 months before randomization
- Participation in another drug study within the 30 days preceding or during the present study
- Severe infection at the index foot according to IDSA classification
- Patient refuses minor amputation despite strong recommendation due to severe infection, necrosis or osteomyelitis at screening assessment
- Non-compliance for any reason to procedures or study assessments (e.g. due to cognitive impairment or geographic distance)
- Untreated known antiphospholipid antibody syndrome and polycythaemia vera
- Known significant bleeding risk, or known coagulation disorder (INR > 3.0 and platelet count < 30,000/mm3) without any option to correct within 7 calendar days after initial wound assessment
- Critical limb ischemia of the index leg defined as ABI ≤ 0.4 (or absolute ankle pressure < 50 mmHg)
- No option to assess for toe pressure due to any reason at baseline if ABI > 0.9 or incompressible ankle pressures and patient inclusion is based on the toe pressure criteria
- Need for major amputation
- Positive urine or blood pregnancy test result, breast feeding or intention to become pregnant
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
This study investigates whether, compared to standard treatment, immediate restoration of blood flow (revascularization) can reduce complications and improve diabetic foot ulcer healing.
A vizsgálat 2 csoportja
- Control ArmMár használt kezelés, összehasonlításként
Standard wound care for diabetic wound ulcer
Kezelés: Standard wound care
- Immediate revascularizationA vizsgált kezelés
Patient will have revascularization 0 - 7 days after initial wound assessment and then receive standard wound care for diabetic wound ulcer
Kezelés: Revascularization és Standard wound care
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Timing of Revascularization in Patients With Diabetic Foot Ulcer and Non-critical Peripheral Artery Disease: a Randomized, Controlled Trial
- A regiszteradat frissítve
- 2024. december 19.